Equity | Sector Equity

Invesco Nasdaq Biotechnology ETF

Ticker: IBBQ
How to invest

Product Details

The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December.

as of 10/31/2022 09/30/2022

Performance

Index History (%) YTD 1Yr 3Yr 5Yr 10Yr Since Inception
Nasdaq Biotechnology Total Return Index (USD) -12.61 -17.03 7.53 5.18 12.08 -13.76
S&P Composite 1500 Biotechnology Total Return Index (USD) 8.60 12.88 12.90 8.17 14.66 6.48
Fund History (%)
Fund NAV -12.71 -17.12 N/A N/A N/A -13.82
After Tax Held -12.93 -17.42 N/A N/A N/A -14.08
After Tax Sold -7.53 -10.08 N/A N/A N/A -10.52
Fund Market Price -12.78 -17.08 N/A N/A N/A -13.82
Index History (%) YTD 1Yr 3Yr 5Yr 10Yr Since Inception
Nasdaq Biotechnology Total Return Index (USD) -19.76 -25.26 7.15 2.17 10.27 -19.99
S&P Composite 1500 Biotechnology Total Return Index (USD) -4.41 -1.45 11.50 3.66 12.72 -3.07
Fund History (%)
Fund NAV -19.84 -25.34 N/A N/A N/A -20.04
After Tax Held -20.04 -25.62 N/A N/A N/A -20.29
After Tax Sold -11.74 -14.93 N/A N/A N/A -15.19
Fund Market Price -19.78 -25.34 N/A N/A N/A -19.95

This is a new Fund and has no full-year Fund performance to report as of most recent quarter end.

Market returns are based on the midpoint of the bid/ask spread at 4 p.m. ET and do not represent the returns an investor would receive if shares were traded at other times. Performance data quoted represents past performance, which is not a guarantee of future results. Investment returns and principal value will fluctuate, and shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than performance data quoted. After-tax returns reflect the highest federal income tax rate but exclude state and local taxes. Fund performance reflects applicable fee waivers, absent which, performance data quoted would have been lower. After Tax Held and After Tax Sold are based on NAV. Returns less than one year are cumulative.

Please keep in mind that high, double-digit and/or triple-digit returns are highly unusual and cannot be sustained.

as of 12/01/2022

Sector Allocation

Sector Percent of Fund
Health Care 100.00%
as of 11/29/2022

Market Cap & Style Allocations

Large-Cap Value 23.75%
Large-Cap Blend 19.72%
Large-Cap Growth 12.05%
Mid-Cap Value 4.47%
Mid-Cap Blend 6.75%
Mid-Cap Growth 12.27%
Small-Cap Value 5.05%
Small-Cap Blend 5.85%
Small-Cap Growth 10.08%

as of 12/01/2022 Top Holdings | View All

Fund Holdings subject to change

Ticker Company % of Fund
GILD Gilead Sciences Inc 9.87
AMGN Amgen Inc 8.48
VRTX Vertex Pharmaceuticals Inc 7.39
REGN Regeneron Pharmaceuticals Inc 7.33
MRNA Moderna Inc 6.38
BIIB Biogen Inc 3.94
AZN AstraZeneca PLC ADR 3.74
ILMN Illumina Inc 3.12
ALNY Alnylam Pharmaceuticals Inc 2.37
HZNP Horizon Therapeutics Plc 2.09

Distributions | HideView All | Distribution Information

Ex-Date Record Date Pay Date $/
Share
Ordinary Income Short Term Gains Long Term Gains Return of Capital Liquidation Distribution
09/19/2022 09/20/2022 09/23/2022 0.03769 0.03769 - - - -
06/21/2022 06/22/2022 06/30/2022 0.04264 0.04264 - - - -
03/21/2022 03/22/2022 03/31/2022 0.03778 0.03778 - - - -
12/20/2021 12/21/2021 12/31/2021 0.10511 0.10511 - - - -

Frequency Distribution of Discounts & Premiums

    Bid/Ask MidPoint Above NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
09/30/2022 64 22 3 0 0 0 0
06/30/2022 62 25 1 0 0 0 0
03/31/2022 62 26 7 0 0 0 0
12/31/2021 64 33 2 0 0 0 0
Year Ended 2021 142 65 3 0 0 0 0
    Bid/Ask Midpoint Below NAV
Quarter
Ending
Days 0.00-
0.25%
0.26-
0.50%
0.51-
0.99%
1.00-
1.49%
1.50-
1.99%
≥2.00%
09/30/2022 64 34 5 0 0 0 0
06/30/2022 62 32 4 0 0 0 0
03/31/2022 62 24 5 0 0 0 0
12/31/2021 64 27 2 0 0 0 0
Year Ended 2021 142 67 7 0 0 0 0

Fund Inception : 06/11/2021

Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices. Performance data quoted represents past performance, which is not a guarantee of future results.

Premiums/Discounts

Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices. Performance data quoted represents past performance, which is not a guarantee of future results.

 Risk & Other Information

Typically, security classifications used in calculating allocation tables are as of the last trading day of the previous month.

There are risks involved with investing in ETFs, including possible loss of money. Shares are not actively managed and are subject to risks similar to those of stocks, including those regarding short selling and margin maintenance requirements. Ordinary brokerage commissions apply. The Fund’s return may not match the return of the Underlying Index. The Fund is subject to certain other risks. Please see the current prospectus for more information regarding the risk associated with an investment in the Fund.

Investments focused in a particular industry, such as biotechnology, are subject to greater risk, and are more greatly impacted by market volatility, than more diversified investments.

Stocks of small and mid-sized companies tend to be more vulnerable to adverse developments, may be more volatile, and may be illiquid or restricted as to resale.

The Fund is non-diversified and may experience greater volatility than a more diversified investment.

The Invesco Nasdaq Biotechnology ETF is not sponsored, endorsed, sold or promoted by the NASDAQ OMX Group, Inc. or its affiliates (NASDAQ OMX, with its affiliates, are referred to as the "Corporations"). The Corporations have no liability in connection with the administration, marketing or trading of the Invesco Nasdaq Biotechnology ETF. "NASDAQ®" is a registered trademark and is used under license.

The S&P Composite 1500® Biotechnology Index consists of all biotechnology stocks included in the S&P Composite 1500® Index.